| Serial Number | 99852895 |
| Word Mark | TAGBIKO |
| Filing Date | Friday, May 29, 2026 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, July 21, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 21, 2026 |
| Pseudo Mark | TAG BIKO |
| Goods and Services | Medicines for human purposes for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs for medical use being medicines for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical use, namely, for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical use, namely, for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; injectable pharmaceuticals for treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude medicines for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biochemical preparations for medical use, namely, the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 29, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BeOne Medicines I GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Basel 4051 CH |
| Party Name | BeOne Medicines I GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Basel 4051 CH |
| Event Date | Event Description |
| Friday, May 29, 2026 | NEW APPLICATION ENTERED |
| Friday, May 29, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 29, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 17, 2026 | ASSIGNED TO EXAMINER |
| Monday, June 22, 2026 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Monday, June 22, 2026 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Monday, June 22, 2026 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Monday, June 22, 2026 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Monday, June 22, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 22, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 22, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 23, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 15, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 21, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 21, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |